← The Wire
OKYONasdaq
OKYO Pharma Ltd
Biological Products, (No Diagnostic Substances) · CIK 1849296
OKYO Pharma develops next-generation therapeutics for inflammatory eye diseases and ocular pain
$80M
Market cap
$1.52
Last close
-1.9%
1D
-3.2%
5D
34K
Volume
Price · last 39 sessions-9.5%
May 4L $1.49 · H $1.72Jun 29
153
Total filings
May 19, 2026
Last filing
—
Fiscal year end
6-K6-KMay 19, 20266-K6-KApr 29, 20266-K6-KApr 7, 20266-K6-KMar 19, 20266-K6-KMar 19, 20266-K6-KMar 19, 20266-K6-KMar 18, 20266-K6-KMar 12, 20266-K6-KFeb 23, 20266-K6-KFeb 13, 20266-K6-KFeb 13, 20266-K6-KFeb 12, 20266-K6-KFeb 11, 20266-K6-KFeb 11, 20266-K6-KFeb 10, 20266-K6-KJan 30, 20266-K6-KJan 30, 20266-K6-KJan 28, 20266-K6-KJan 23, 20266-K6-KJan 5, 20266-K6-KDec 19, 20256-K6-KDec 15, 20256-K6-KDec 11, 20256-K6-KDec 3, 20256-K6-KNov 21, 20256-K6-KNov 18, 20256-K6-KOct 29, 20256-K6-KOct 16, 20256-K6-KSep 22, 20256-K6-KJul 17, 20256-K6-KJul 16, 20256-K6-KJun 11, 20256-K6-KMay 19, 20256-K6-KMay 1, 20256-K6-KApr 30, 20256-K6-KMar 31, 20256-K6-KMar 10, 20256-K6-KFeb 12, 20256-K6-KJan 31, 20256-K6-KJan 29, 20256-K6-KJan 22, 20256-K6-KNov 26, 20246-K6-KOct 30, 20246-K6-KOct 23, 20246-K6-KOct 16, 20246-K6-KSep 10, 20246-K6-KSep 5, 20246-K6-KAug 27, 20246-K6-KAug 23, 20246-K6-KAug 23, 20246-K6-KAug 21, 20246-K6-KAug 15, 20246-K6-KAug 6, 20246-K6-KJul 11, 20246-K6-KJul 10, 20246-K6-KJul 10, 20246-K6-KMay 8, 20246-K6-KApr 30, 20246-K6-KApr 9, 20246-K6-KApr 4, 20246-K6-KApr 2, 20246-K6-KMar 29, 20246-K6-KMar 22, 20246-K6-KMar 21, 20246-K6-KMar 20, 20246-K6-KFeb 9, 20246-K6-KJan 31, 20246-K6-KJan 8, 20246-K6-KJan 5, 20246-K6-KDec 21, 20236-K6-KDec 18, 20236-K6-KDec 4, 20236-K6-KNov 29, 20236-K6-KNov 1, 20236-K6-KOct 31, 20236-K6-KOct 10, 20236-K6-KOct 5, 20236-K6-KSep 15, 20236-K6-KSep 15, 20236-K6-KSep 14, 2023
Similar companies
Comparable business profile · signals at a glance